Financial statements Pharmabroker
Balance sheet data of PHARMABROKER
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 54 904,46 | 60 116,91 | 55 174,61 | 52 834,34 | 317 486,49 | 330 920,46 |
| A. Fixed assets | 100,00 | 100,00 | 100,00 | 100,00 | 100,00 | 100,00 |
| B. Current assets | 54 804,46 | 60 016,91 | 55 074,61 | 52 734,34 | 317 386,49 | 330 820,46 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 54 904,46 | 60 116,91 | 55 174,61 | 52 834,34 | 317 486,49 | 330 920,46 |
| A. Equity | 22 560,10 | 27 691,97 | 21 739,65 | 17 688,83 | 281 294,12 | 285 765,77 |
| B. Liabilities and provisions for liabilities | 32 344,36 | 32 424,94 | 33 434,96 | 35 145,51 | 36 192,37 | 45 154,69 |
| I. Long-term liabilities | 21 000,00 | 21 705,75 | 22 230,75 | 22 230,75 | 23 280,75 | 23 805,75 |
| II. Short-term liabilities | 11 344,36 | 10 719,19 | 11 204,21 | 12 914,76 | 12 911,62 | 21 348,94 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.